Search Results - "de Salvo, L"

C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition by Cannistraci, A, Federici, G, Addario, A, Di Pace, A L, Grassi, L, Muto, G, Collura, D, Signore, M, De Salvo, L, Sentinelli, S, Simone, G, Costantini, M, Nanni, S, Farsetti, A, Coppola, V, De Maria, R, Bonci, D

“…Although a significant subset of prostate tumors remain indolent during the entire life, the advanced forms are still one of the leading cause of…”
Get full text

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma by Caccese, M., Desideri, I., Villani, V., Simonelli, M., Buglione, M., Chiesa, S., Franceschi, E., Gaviani, P., Stasi, I., Caserta, C., Brugnara, S., Lolli, I., Bennicelli, E., Bini, P., Cuccu, A.S., Scoccianti, S., Padovan, M., Gori, S., Bonetti, A., Giordano, P., Pellerino, A., Gregucci, F., Riva, N., Cinieri, S., Internò, V., Santoni, M., Pernice, G., Dealis, C., Stievano, L., Paiar, F., Magni, G., De Salvo, G.L., Zagonel, V., Lombardi, G.

“…In the randomized phase II REGOMA trial, regorafenib showed promising activity in patients with recurrent glioblastoma. We conducted a large, multicenter,…”
Get full text

Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups by Merks, J.H.M., De Salvo, G.L., Bergeron, C., Bisogno, G., De Paoli, A., Ferrari, A., Rey, A., Oberlin, O., Stevens, M.C.G., Kelsey, A., Michalski, J., Hawkins, D.S., Anderson, J.R.

“…Parameningeal (PM) site is a well-known adverse prognostic factor in children with localized rhabdomyosarcoma (RMS). To identify risk factors associated with…”
Get full text

Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab by Zulato, E, Bergamo, F, De Paoli, A, Griguolo, G, Esposito, G, De Salvo, G L, Mescoli, C, Rugge, M, Nardin, M, Di Grazia, L, Lonardi, S, Indraccolo, S, Zagonel, V

“…Background: AMP-activated protein kinase (AMPK) has a central role in cellular energy sensing and is activated in preclinical tumour models following…”
Get full text

Spectrum, temporal structure, and fluctuations in a high-gain free-electron laser starting from noise by Bonifacio, R, De Salvo L, Pierini, P, Piovella, N, Pellegrini, C

Get full text

Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study by Basso, U., Fratino, L., Brunello, A., Lumachi, F., De Salvo, G.L., Lonardi, S., Ghiotto, C., Koussis, H., Pasetto, L.M., Monfardini, S.

“…Background: Since vinorelbine and gemcitabine are both active in breast cancer with moderate toxicity, in 2002 we started a phase II trial with a combination…”
Get full text

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients by Chiarion-Sileni, V., Del Bianco, P., De Salvo, G.L., Re, G.Lo, Romanini, A., Labianca, R., Nortilli, R., Corgna, E., Palma, M.Dalla, Presti, G.Lo, Ridolfi, R.

“…This study analyses the health related quality of life (HRQOL) of advanced melanoma patients, in a randomised trial comparing bio-chemotherapy (bio-CT) versus…”
Get full text

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features by De Moliner, L, Pontisso, P, De Salvo, G L, Cavalletto, L, Chemello, L, Alberti, A

“…Background—Liver disease in chronic hepatitis C virus (HCV) infection ranges from minimal lesions to liver cirrhosis, eventually evolving to hepatocellular…”
Get full text

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study by Guarneri, V., Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., De Salvo, G.L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C.A., Moretti, G., Griguolo, G., Vicini, R., Prat, A., Conte, P.F.

“…In human epidermal growth factor receptor 2 (HER2+) breast cancers, neoadjuvant trials of chemotherapy plus anti-HER2 treatment consistently showed lower…”
Get full text

Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) – RMS2005 study by Glosli, Heidi, Bisogno, Gianni, Kelsey, Anna, Chisholm, Julia C., Gaze, Mark, Kolb, Frederic, McHugh, Kieran, Shipley, Janet, Gallego, Soledad, Merks, Johannes H.M., Smeele, Ludi E., Mandeville, Henry, Ferrari, Andrea, Minard-Colin, Veronique, Corradini, Nadege, Jenney, Meriel, Zanetti, Ilaria, De Salvo, Gian L., Orbach, Daniel

“…The primary aim of this study was to analyse and evaluate the impact of different local treatments on the pattern of relapse in children with primary head and…”
Get full text

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial by Guarneri, Valentina, Giorgi, Carlo Alberto, Cinieri, Saverio, Bengala, Carmelo, Mariani, Gabriella, Bisagni, Giancarlo, Frassoldati, Antonio, Zamagni, Claudio, De Rossi, Costanza, Amoroso, Vito, Andreetta, Claudia, Ferro, Antonella, Zambelli, Alberto, Gori, Stefania, Garrone, Ornella, Dieci, Maria Vittoria, Orlando, Laura, Pastina, Ilaria, Beninato, Teresa, Moretti, Gabriella, Genovesi, Elisa, Cinefra, Margherita, Vicini, Roberto, Magni, Giovanna, De Salvo, Gian L., Conte, PierFranco

“…Despite endocrine therapy being the mainstay of treatment for hormone receptor positive (HR+)/HER2− metastatic breast cancer, patients at risk of visceral…”
Get full text

Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005) by Ferrari, A., De Salvo, G.L., Brennan, B., van Noesel, M.M., De Paoli, A., Casanova, M., Francotte, N., Kelsey, A., Alaggio, R., Oberlin, O., Carli, M., Ben-Arush, M., Bergeron, C., Merks, J.H.M., Jenney, M., Stevens, M.C., Bisogno, G., Orbach, D.

“…The paper report the results of the first European prospective nonrandomized trial dedicated to pediatric synovial sarcoma. The study included 138 patients…”
Get full text

Treatment efficacy with electrochemotherapy: a multi-institutional prospective observational study on 376 patients with superficial tumors by Campana, L.G., M.D., Ph.D, Testori, A, Curatolo, P, Qaglino, P, Mocellin, S, Framarini, M, Borgognoni, L, Ascierto, P.A, Mozzillo, N, Guida, M, Bucher, S, Rotunno, R, Marenco, F, De Salvo, G.L, De Paoli, A, Rossi, C.R, Bonadies, A

“…Abstract Background Cutaneous metastases represent a therapeutic challenge. An increasing body of experience suggests that electrochemotherapy (ECT) provides…”
Get full text

Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer by Pucciarelli, S., Del Bianco, P., Pace, U., Bianco, F., Restivo, A., Maretto, I., Selvaggi, F., Zorcolo, L., De Franciscis, S., Asteria, C., Urso, E. D. L, Cuicchi, D., Pellino, G., Morpurgo, E., La Torre, G., Jovine, E., Belluco, C., La Torre, F., Amato, A., Chiappa, A., Infantino, A., Barina, A., Spolverato, G., Rega, D., Kilmartin, D., De Salvo, G. L., Delrio, P.

“…Background Colonic J pouch reconstruction has been found to be associated with a lower incidence of anastomotic leakage than straight anastomosis. However,…”
Get full text

Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients by Zavagno, G., Carcoforo, P., Franchini, Z., Renier, M., Barutta, L., De Salvo, G.L., Maravegias, K., Capitanio, G., Nitti, D., Lise, M.

“…To determine the axillary recurrence rate in breast cancer patients with negative sentinel lymph nodes (SLN) who did not undergo further axillary lymph node…”
Get full text

Administration of Samital® in children with oral mucositis: a feasibility study by Massano, D, Paratella, A, Affinita, M C, De Salvo, G L, Petrangolini, G, Riva, A, Bisogno, G

“…SAMITAL®, a botanical drug containing three highly standardized extracts (Vaccinium myrtillus, Macleaya cordata and Echinacea angustifolia), has shown…”
Get more information

Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinella–GIVOM Italian randomised clinical trial by Del Bianco, P, Zavagno, G, Burelli, P, Scalco, G, Barutta, L, Carraro, P, Pietrarota, P, Meneghini, G, Morbin, T, Tacchetti, G, Pecoraro, P, Belardinelli, V, De Salvo, G.L

“…Abstract Aims To compare physical morbidity and health-related quality of life (HRQOL) in breast cancer patients who received standard axillary dissection…”
Get full text

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens by Chiarion-Sileni, V, Guida, M, Ridolfi, L, Romanini, A, Del Bianco, P, Pigozzo, J, Brugnara, S, Colucci, G, Ridolfi, R, De Salvo, G L

“…Background: This study compared the central nervous system (CNS) metastasis incidence between a temozolomide- and a dacarbazine-based regimen in untreated…”
Get full text

First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER+/HER2- early breast cancer (BC) patients by Dieci, M V, Guarneri, V, Giarratano, T, Mion, M, Tortora, G, Morandi, P, Gori, S, Merlini, L, Oliani, C, Pasini, F, Bonciarelli, G, Griguolo, G, Orvieto, E, Del Bianco, P, De Salvo, G L, Conte, P

Get full text

Pseudodiverticular defecographic image after STARR procedure for outlet obstruction syndrome by Frascio, M, Lazzara, F, Stabilini, C, Fornaro, R, De Salvo, L, Mandolfino, F, Ricci, B, Gianetta, E

Get full text